News for Vanda Pharmaceuticals Inc. (0LKB.L)

On March 6, 2025, Mihael Polymeropoulos, President and Chief Executive Officer of Vanda Pharmaceuticals Inc, purchased 10,000 shares of the company. Following t

On February 28, 2025, Mihael Polymeropoulos, President and Chief Executive Officer of Vanda Pharmaceuticals Inc, purchased 10,000 shares of the company, accordi

On February 27, 2025, Mihael Polymeropoulos, President and Chief Executive Officer of Vanda Pharmaceuticals Inc (VNDA), purchased 10,000 shares of the company.

On February 26, 2025, Mihael Polymeropoulos, President and Chief Executive Officer of Vanda Pharmaceuticals Inc, purchased 10,000 shares of the company. Followi

On February 25, 2025, Mihael Polymeropoulos, President and Chief Executive Officer of Vanda Pharmaceuticals Inc, purchased 10,000 shares of the company, accordi

PR NewswireWASHINGTON, Feb. 24, 2025 WASHINGTON, Feb. 24, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the public

Operator: Hello, and thank you for standing by. At this time, I would like to welcome you to the Q4 2024 Vanda Pharmaceuticals Inc. Earnings Conference Call.

Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ETCompany ParticipantsKevin Moran - SVP, CFO &...

On January 31, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction involving Vanda Pharmaceuticals Inc. The firm reduced its holdings b

PR NewswireWASHINGTON and SAN DIEGO, Feb. 3, 2025 Imsidolimab has successfully completed two global Phase 3 studies in Generalized Pustular PsoriasisVanda

PR NewswireWASHINGTON, Jan. 27, 2025 Highlights faulty FDA reviewWASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA

PR NewswireWASHINGTON, Dec. 20, 2024 WASHINGTON, Dec. 20, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. F

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsKevin Moran – Chief Financial...

As September unfolds, let us review some of the regulatory news that made headlines last month and look ahead to what this month has in store..

Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference

Vanda Pharmaceuticals Inc. received and then refused two takeover bids that were well above current market prices. Learn why I'm highly bullish on VNDA stock.

Vanda Pharmaceuticals Inc. (NASDAQ:NASDAQ:VNDA) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ETCompany ParticipantsKevin Moran - Chief Financial...

Total Revenues (First Six Months 2024): $97.9 million, a 10% decrease compared to $108.6 million for the same period in 2023.Fanapt Net Product Sales (First Si

Jul 31, 2024 / 08:30PM GMTOperator Thank you for standing by. My name is Meg, and I will be your conference operator today. At this time, I would like to welcom